These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 23519385

  • 21. Dabigatran: how the drug company withheld important analyses.
    Cohen D.
    BMJ; 2014 Jul 23; 349():g4670. PubMed ID: 25055829
    [No Abstract] [Full Text] [Related]

  • 22. Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits.
    Yau JW, Liao P, Fredenburgh JC, Roberts RS, Weitz JI.
    Thromb Haemost; 2014 Jul 03; 112(1):79-86. PubMed ID: 24573541
    [Abstract] [Full Text] [Related]

  • 23. Traumatic intracranial hemorrhage in patients taking dabigatran: report of 3 cases and review of the literature.
    Wassef SN, Abel TJ, Grossbach A, Viljoen SV, Jackson AW, Howard MA, Greenlee JD.
    Neurosurgery; 2013 Aug 03; 73(2):E368-73; discussion E373-4. PubMed ID: 23670031
    [Abstract] [Full Text] [Related]

  • 24. Removal of dabigatran by hemodialysis.
    Chang DN, Dager WE, Chin AI.
    Am J Kidney Dis; 2013 Mar 03; 61(3):487-9. PubMed ID: 23219111
    [Abstract] [Full Text] [Related]

  • 25. Application of the RELY study to lifetime risks of atrial fibrillation: implications for spontaneous intracranial hemorrhage.
    Parry PV, Engh JA.
    Neurosurgery; 2012 Feb 03; 70(2):N10-1. PubMed ID: 22251978
    [No Abstract] [Full Text] [Related]

  • 26. The trouble with dabigatran.
    Charlton B, Redberg R.
    BMJ; 2014 Jul 23; 349():g4681. PubMed ID: 25055830
    [No Abstract] [Full Text] [Related]

  • 27. Wandering pneumonia caused by dabigatran.
    Kono M, Hirota K, Yokoe A, Koumura C, Sakai T, Tojima H.
    Intern Med; 2014 Jul 23; 53(16):1825-7. PubMed ID: 25130119
    [Abstract] [Full Text] [Related]

  • 28. Dabigatran: patient management in specific clinical settings.
    Kyrle PA, Binder K, Eichinger S, Függer R, Gollackner B, Hiesmayr JM, Huber K, Lang W, Perger P, Quehenberger P, Roithinger FX, Schmaldienst S, Weltermann A, Domanovits H.
    Wien Klin Wochenschr; 2014 Sep 23; 126(17-18):503-8. PubMed ID: 25138549
    [Abstract] [Full Text] [Related]

  • 29. Management of dabigatran-induced bleeding: expert statement.
    Fries D, Giurea A, Gütl M, Halbmayer WM, Kozek-Langenecker S, Pachucki A, Roithinger F, Steinlechner B, Thaler H, Weltermann A.
    Wien Klin Wochenschr; 2013 Nov 23; 125(21-22):721-9. PubMed ID: 24217941
    [Abstract] [Full Text] [Related]

  • 30. [Extensive thromboembolism after cardioversion in a patient treated with dabigatran].
    Buch TN, Holm J, Munck LK.
    Ugeskr Laeger; 2013 Feb 04; 175(6):333-4. PubMed ID: 23402235
    [Abstract] [Full Text] [Related]

  • 31. The use, misuse and abuse of dabigatran.
    Attia JR, Pearce R.
    Med J Aust; 2013 Apr 15; 198(7):356-7. PubMed ID: 23581945
    [Abstract] [Full Text] [Related]

  • 32. Dabigatran: a primer for neurosurgeons.
    Fugate JE, Rabinstein AA, McBane RD, Lanzino G.
    World Neurosurg; 2013 Jan 15; 79(1):154-8. PubMed ID: 22722043
    [Abstract] [Full Text] [Related]

  • 33. Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction?
    Dale B, Eikelboom JW, Weitz JI, Young E, Paikin JS, Coppens M, Whitlock RP, Connolly SJ, Ginsberg JS, Hirsh J.
    J Thromb Thrombolysis; 2013 Feb 15; 35(2):295-301. PubMed ID: 23242974
    [Abstract] [Full Text] [Related]

  • 34. Concerns over data in key dabigatran trial.
    Cohen D.
    BMJ; 2014 Jul 23; 349():g4747. PubMed ID: 25055831
    [No Abstract] [Full Text] [Related]

  • 35. Gastrointestinal bleeding under dabigatran.
    Stöllberger C, Lindner K, Finsterer J.
    J Postgrad Med; 2014 Jul 23; 60(2):192-3. PubMed ID: 24823522
    [Abstract] [Full Text] [Related]

  • 36. Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.
    Hoffman M, Volovyk Z, Monroe DM.
    Anesthesiology; 2015 Feb 23; 122(2):353-62. PubMed ID: 25502064
    [Abstract] [Full Text] [Related]

  • 37. The untold story of Dabigatran etexilate: alveolar hemorrhage in an elderly patient with interstitial pulmonary fibrosis.
    Husari A, Beydoun A, Sheik Ammar A, Maakaron JE, Taher A.
    J Thromb Thrombolysis; 2013 Jan 23; 35(1):81-2. PubMed ID: 22843168
    [Abstract] [Full Text] [Related]

  • 38. Dabigatran overdose secondary to acute kidney injury and amiodarone use.
    Fountzilas C, George J, Levine R.
    N Z Med J; 2013 Mar 01; 126(1370):110-2. PubMed ID: 23474519
    [Abstract] [Full Text] [Related]

  • 39. [Two cases of dabigatran-induced esophageal ulcer indicating the usefulness of drug administration guidance].
    Izumikawa K, Inaba T, Mizukawa S, Kawai Y, Sakakihara I, Ishikawa S, Miyoshi M, Wato M, Kawai K.
    Nihon Shokakibyo Gakkai Zasshi; 2014 Jun 01; 111(6):1096-104. PubMed ID: 24898488
    [Abstract] [Full Text] [Related]

  • 40. Dabigatran "non-inferior" to warfarin, but only just.
    BMJ; 2013 Feb 27; 346():f1219. PubMed ID: 23447339
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.